Is GOVX Worth Buying in 2026?

GeoVax Labs, Inc. New

STOCK PHARMACEUTICAL PREPARATIONS Updated 2026-06-14

Here’s whether GeoVax Labs, Inc. New (GOVX) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Bearish.

🔴
Bearish

Positives: 50-day MA is rising (+2.07% over 10 days). Concerns: trading below the 200-day MA (long-term downtrend); below the 50-day MA (medium-term momentum negative); RSI 7 — oversold; weak 1-year return of -95.7%; 3-month momentum negative (-28.6%). Currently 96.5% off its 52-week high. Score: -5/7.

Ready to act on this? 📈 Trade on Webull

GOVX is trading below its 200-day MA ($6.70) — a key warning sign the longer-term trend is under pressure. An RSI of 6.8 has dropped into oversold territory, which has historically preceded short-term bounces. The 1-year return of -95.7% compares to +22.9% for SPY (trailed the market by 118.6%). The current 96.5% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.

$10,000 invested 1 year ago → $428 today
vs. S&P 500 (SPY) — same period trailed market by 118.6%

1-Year Price Chart

Daily candles
MA-50 MA-200 Up Down

Signal Check

Above 200-day MA ($6.70)
Above 50-day MA ($1.58)
!RSI(14) neutral zone (30–70) — currently 6.8
Positive return (-95.7%)
!Within 10% of period high (−96.5%)
Period Range $1.22
$0.96 $34.75
RSI (14) 6.8
0 · OversoldOverbought · 100

Key Metrics

Price$1.22
Period Return-95.7%
Period High$34.75
Period Low$0.96
Drawdown−96.5%
MA-50$1.58
MA-200$6.70
RSI (14)6.8
Avg Volume (30d)10.3M
vs. SPYtrailed by 118.6%
Return Rank#1210 of 1246

Trade GOVX

📈 Trade on Webull 📊 Trade on moomoo 💹 Interactive Brokers